Related Experiment Videos
Tumorigenesis with 1,1-diallylhydrazine in mice
Anticancer Research
|January 1, 1981
Summary
1,1-Diallylhydrazine significantly increased lung and forestomach tumor incidence in Swiss mice. This study highlights the carcinogenic potential of disubstituted allylhydrazines in animal models.
Area of Science:
- Toxicology
- Carcinogenesis
- Oncology
Background:
- Hydrazine derivatives are known for their potential toxicity and carcinogenicity.
- Structure-activity relationship studies are crucial for understanding chemical carcinogens.
Purpose of the Study:
- To evaluate the carcinogenic potency of 1,1-diallylhydrazine.
- To assess the impact of 1,1-diallylhydrazine on tumor development in specific organs.
Main Methods:
- Administration of 1,1-diallylhydrazine in drinking water to Swiss mice for their lifetime, starting at 6 weeks of age.
- Comparison of tumor incidence between treated and untreated control groups.
- Histopathological classification of induced tumors.
Main Results:
- A significant increase in lung tumor incidence was observed in both female (25% to 76%) and male (26% to 76%) mice.
- Forestomach tumor incidence rose from 4% to 14% in females and from 0% to 34% in males.
- Tumors included lung adenomas/adenocarcinomas and forestomach squamous cell papillomas/carcinomas.
Conclusions:
- 1,1-Diallylhydrazine is a potent carcinogen, inducing significant increases in lung and forestomach tumors in mice.
- This finding contributes to the understanding of structure-activity relationships for allylhydrazine carcinogenicity.